Neuraxis NRXS
NYSE NRXS
$5.64 -0.13 (-2.15%)
As of: Sep 10, 2026 · 9:46 AM EDT

Neuraxis (NRXS) Revenue (2022 - 2025)

Neuraxis' (NRXS) quarterly Revenue came in at $968127.0 in Q4 2025, up 27.19% year-over-year from $761165.0 in Q4 2024, and up 19.31% quarter-over-quarter from $811414.0 in Q3 2025.

Analysis

Neuraxis (NRXS) Revenue (2022 - 2025) Analysis & Trends

Neuraxis has disclosed Revenue across 4 years of filings, most recently posting $968127.0 for Q4 2025.

  • In Q4 2025, Revenue rose 27.19% year-over-year to $968127.0; the TTM figure through Dec 2025 stood at $3.6 million (up 32.89% YoY), while the FY2025 annual figure was $3.6 million, up 32.89% from the prior year.
  • Revenue came in at $968127.0 for Q4 2025 at Neuraxis, up from $811414.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $968127.0 in Q4 2025 to a low of $477460.0 in Q3 2023.
  • Average Revenue over 4 years is $708648.3, with a median of $666625.0 recorded in 2024.
  • Year-over-year, Revenue decreased 22.84% in 2023 and soared 46.21% in 2025.
  • Over 4 years, Revenue stood at $613082.0 in 2022, then declined by 13.31% to $531459.0 in 2023, then surged by 43.22% to $761165.0 in 2024, then advanced by 27.19% to $968127.0 in 2025.
  • Per Business Quant data, the three most recent Revenue figures were $968127.0 in Q4 2025, $811414.0 in Q3 2025, and $894086.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Abbott Laboratories 182.70 Bn 177.10 Bn 7.27 Bn 12.59 Bn
2 Intuitive Surgical 126.56 Bn 121.34 Bn 1.96 Bn 2.89 Bn
3 Medtronic 118.15 Bn 109.33 Bn 6.34 Bn 9.76 Bn
4 Stryker 104.94 Bn 101.46 Bn 4.50 Bn 6.59 Bn
5 Boston Scientific 64.79 Bn 64.25 Bn 3.85 Bn 5.44 Bn
6 Edwards Lifesciences 49.87 Bn 45.62 Bn 1.35 Bn 1.74 Bn
7 Alcon 33.04 Bn 31.59 Bn 1.68 Bn 2.78 Bn
8 Dexcom 32.07 Bn 30.13 Bn 830.00 Mn 1.31 Bn
9 Steris 20.78 Bn 20.29 Bn 684.20 Mn 1.49 Bn
10 Neuraxis 68.42 Mn 60.09 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 968,127.00
Sep 30, 2025 811,414.00
Jun 30, 2025 894,086.00
Mar 31, 2025 895,655.00
Dec 31, 2024 761,165.00
Sep 30, 2024 666,625.00
Jun 30, 2024 611,500.00
Mar 31, 2024 646,635.00
Dec 31, 2023 531,459.00
Sep 30, 2023 477,460.00
Jun 30, 2023 646,021.00
Mar 31, 2023 805,110.00
Dec 31, 2022 613,082.00
Sep 30, 2022 618,805.00
Jun 30, 2022 682,581.00